Access cutting-edge episodic migraine treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access episodic migraine specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related episodic migraine treatment provided free
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Sponsor: Eli Lilly and Company
Check if you qualify for this episodic migraine clinical trial in Phoenix, AZ
If you're searching for episodic migraine treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced episodic migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.